iPSC Seminars: Early Drug Discovery Unit (EDDU) (Virtual)
To register: LINK
(The event will be taking place over Zoom)
Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD.
Ashutosh Dhingra, Ph.D.
German Center for Neurodegenerative Diseases (DZNE)-Tübingen
Targeting miR-22-3p to enhance GBA1 levels and GCase activity in iPSC-derived models of Parkinson’s disease.
The Neuro's Early Drug Discovery Unit (EDDU), Canada
Supported by Healthy Brains for Healthy Lives and STEMCELL Technologies, The Neuro's iPSC Seminar Series welcomes trainees and senior scientists working with induced pluripotent stem cells (iPSCs) to present their cutting-edge research. The Seminar Series intends to foster collaborations within the network of laboratories working with iPSCs in Montreal, Canada, and around the world. Who should attend: research staff and trainees.
Event coordinators: Rina Shlaifer and Luisa Pimentel